欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4682/001
药品名称Miprosed 5mg/ml Oral Solution
活性成分
    • Midazolam 5.0 mg/ml
剂型Oral solution
上市许可持有人Syri Pharma Limited 1 Windmill Lane D02 F206 Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Miprosed 5mg/ml Oral Solution
互认成员国 - 产品名称
    • Denmark (DK)
      Miprosed
    • United Kingdom (Northern Ireland) (XI)
    • Malta (MT)
      Miprosed Smg/ml Oral Solution
许可日期2020/04/28
最近更新日期2024/09/23
药物ATC编码
    • N05CD08 midazolam
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase